General Information of the Compound
| Compound ID |
CP0380341
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
3-[3-[[3-[2-[(3-chlorobenzoyl)amino]ethylamino]phenyl]sulfamoyl]-4-methoxyphenyl]-N,N-dimethylbenzamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C31H31ClN4O5S
|
||||||||||||||||||
| Molecular Weight |
607.132
|
||||||||||||||||||
| Canonical SMILES |
COc1ccc(cc1S(=O)(=O)Nc1cccc(NCCNC(=O)c2cccc(Cl)c2)c1)-c1cccc(c1)C(=O)N(C)C
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C31H31ClN4O5S/c1-36(2)31(38)24-9-4-7-21(17-24)22-13-14-28(41-3)29(19-22)42(39,40)35-27-12-6-11-26(20-27)33-15-16-34-30(37)23-8-5-10-25(32)18-23/h4-14,17-20,33,35H,15-16H2,1-3H3,(H,34,37)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AWAJOBNPSUMXDW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01132, Orexin receptor type 2
Protein ID: PT02001, Orexin/Hypocretin receptor type 1